197 related articles for article (PubMed ID: 31961467)
21. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
Cowart K; Worley M; Rouby NE; Sando K
Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
[No Abstract] [Full Text] [Related]
22. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
23. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
[TBL] [Abstract][Full Text] [Related]
24. Quality care opportunities: refining physician performance measurement in ambulatory care.
Lovett KM; Liang BA
Am J Manag Care; 2012 Jun; 18(6):e212-6. PubMed ID: 22775072
[TBL] [Abstract][Full Text] [Related]
25. Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR).
Arnold SV; McGuire DK; Inzucchi SE; Tang F; Mehta SN; Lam CSP; Goyal A; Sperling LS; Wong ND; Hammar N; Fenici P; Kosiborod M
J Diabetes Complications; 2018 Nov; 32(11):1035-1039. PubMed ID: 30177468
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements.
Shekhani R; Steinacher L; Swen JJ; Ingelman-Sundberg M
Clin Pharmacol Ther; 2020 May; 107(5):1240-1255. PubMed ID: 31715018
[TBL] [Abstract][Full Text] [Related]
27. Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.
Hicks JK; El Rouby N; Ong HH; Schildcrout JS; Ramsey LB; Shi Y; Anne Tang L; Aquilante CL; Beitelshees AL; Blake KV; Cimino JJ; Davis BH; Empey PE; Kao DP; Lemkin DL; Limdi NA; P Lipori G; Rosenman MB; Skaar TC; Teal E; Tuteja S; Wiley LK; Williams H; Winterstein AG; Van Driest SL; Cavallari LH; Peterson JF;
Clin Pharmacol Ther; 2021 Jul; 110(1):179-188. PubMed ID: 33428770
[TBL] [Abstract][Full Text] [Related]
28. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Amstutz U; Henricks LM; Offer SM; Barbarino J; Schellens JHM; Swen JJ; Klein TE; McLeod HL; Caudle KE; Diasio RB; Schwab M
Clin Pharmacol Ther; 2018 Feb; 103(2):210-216. PubMed ID: 29152729
[TBL] [Abstract][Full Text] [Related]
29. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
Stingl JC; Brockmöller J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
[TBL] [Abstract][Full Text] [Related]
30. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
Luzum JA; Pakyz RE; Elsey AR; Haidar CE; Peterson JF; Whirl-Carrillo M; Handelman SK; Palmer K; Pulley JM; Beller M; Schildcrout JS; Field JR; Weitzel KW; Cooper-DeHoff RM; Cavallari LH; O'Donnell PH; Altman RB; Pereira N; Ratain MJ; Roden DM; Embi PJ; Sadee W; Klein TE; Johnson JA; Relling MV; Wang L; Weinshilboum RM; Shuldiner AR; Freimuth RR;
Clin Pharmacol Ther; 2017 Sep; 102(3):502-510. PubMed ID: 28090649
[TBL] [Abstract][Full Text] [Related]
31. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
32. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
[TBL] [Abstract][Full Text] [Related]
33. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Caudle KE; Klein TE; Hoffman JM; Muller DJ; Whirl-Carrillo M; Gong L; McDonagh EM; Sangkuhl K; Thorn CF; Schwab M; Agundez JA; Freimuth RR; Huser V; Lee MT; Iwuchukwu OF; Crews KR; Scott SA; Wadelius M; Swen JJ; Tyndale RF; Stein CM; Roden D; Relling MV; Williams MS; Johnson SG
Curr Drug Metab; 2014 Feb; 15(2):209-17. PubMed ID: 24479687
[TBL] [Abstract][Full Text] [Related]
34. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
[TBL] [Abstract][Full Text] [Related]
35. Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.
Borobia AM; Dapia I; Tong HY; Arias P; Muñoz M; Tenorio J; Hernández R; García García I; Gordo G; Ramírez E; Frías J; Lapunzina P; Carcas AJ
Clin Transl Sci; 2018 Mar; 11(2):189-199. PubMed ID: 29193749
[TBL] [Abstract][Full Text] [Related]
36. Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics.
Liu D; Olson KL; Manzi SF; Mandl KD
Genet Med; 2021 Apr; 23(4):782-786. PubMed ID: 33420348
[TBL] [Abstract][Full Text] [Related]
37. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
[TBL] [Abstract][Full Text] [Related]
38. Breast Implant Imaging Surveillance among U.S. Plastic Surgeons: U.S. Food and Drug Administration Recommendations versus Clinical Reality.
Carr LW; Roberts J; Mericli AF; Liu J; Arribas EM; Clemens MW
Plast Reconstr Surg; 2020 Jun; 145(6):1381-1387. PubMed ID: 32459768
[TBL] [Abstract][Full Text] [Related]
39. The use of pharmacogenetic testing in psychiatry.
Kumar A; Kearney A
J Am Assoc Nurse Pract; 2021 Nov; 33(11):849-851. PubMed ID: 34747904
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics: a general review on progress to date.
Daly AK
Br Med Bull; 2017 Dec; 124(1):65-79. PubMed ID: 29040422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
